Atlanta, GEORGIA9 Active Studies

Head and Neck Cancer Clinical Trials in Atlanta, GEORGIA

Find 9 actively recruiting head and neck cancer clinical trials in Atlanta, GEORGIA. Connect with local research sites and explore new treatment options.

9
Active Trials
9
Sponsors
2,515
Enrolling

Recruiting Head and Neck Cancer Studies in Atlanta

RecruitingAtlanta, GEORGIANCT05451004

SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer

This study is being done to answer the following question: Is the chance of cancer spreading or returning the same if radiotherapy to the neck is guided, by using a special imaging study called lymph...

510 participants
Canadian Cancer Trials Group
View Study Details
RecruitingAtlanta, GEORGIANCT04892173

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

This is a global, open-label, randomized, 2-arm, Investigator's choice Phase 3 (Pivotal Stage) study to investigate the efficacy and safety of JNJ-90301900 (NBTXR3) / radiation therapy (RT)±cetuximab ...

500 participants
Johnson & Johnson Enterprise Innovation Inc.
View Study Details
RecruitingAtlanta, GEORGIANCT06064877

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

The purpose of this study is to compare the efficacy and safety of ficlatuzumab plus cetuximab compared to placebo plus cetuximab in participants with recurrent/metastatic (R/M) HPV-negative Head and ...

410 participants
AVEO Pharmaceuticals, Inc.
View Study Details
RecruitingAtlanta, GEORGIANCT04534205

A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1

An open-label, controlled, multi-site, interventional, 2-arm, Phase II/III trial of BNT113 in combination with pembrolizumab vs pembrolizumab monotherapy as first line treatment in patients with unres...

350 participants
BioNTech SE
View Study Details
RecruitingAtlanta, GEORGIANCT05721755

Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck

This phase III trial compares pembrolizumab with radiation therapy to pembrolizumab without radiation therapy (standard therapy) given after pembrolizumab plus chemotherapy for the treatment of patien...

290 participants
ECOG-ACRIN Cancer Research Group
View Study Details
RecruitingAtlanta, GEORGIANCT04915183

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

Background: Cisplatin is used to treat head and neck cancer. People who take this drug are at risk for hearing loss. Atorvastatin is a drug used to treat high cholesterol. It might reduce the risk of...

224 participants
National Institute on Deafness and Other Communication Disorders (NIDCD)
View Study Details
RecruitingAtlanta, GEORGIANCT06457503

A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer

This study aims to investigate toripalimab with chemotherapy in participants with nasopharyngeal cancer....

100 participants
Coherus Oncology, Inc.
View Study Details
RecruitingAtlanta, GEORGIANCT05814666

Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC

Open-label, Phase II, randomized, controlled study evaluating the efficacy and safety of danvatirsen in combination with pembrolizumab compared with pembrolizumab alone as first-line treatment of pati...

81 participants
Flamingo Therapeutics NV
View Study Details
RecruitingAtlanta, GEORGIANCT05904080

Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer

This phase II trial tests how well nivolumab and ipilimumab immunotherapy with or without cabozantinib works in treating patients with nasopharyngeal cancer that has come back (after a period of impro...

50 participants
National Cancer Institute (NCI)
View Study Details

About Head and Neck Cancer Clinical Trials in Atlanta

Head and neck cancers develop in the mouth, throat, larynx, sinuses, or salivary glands. HPV-related oropharyngeal cancers have been increasing in prevalence. Treatment includes surgery, radiation, chemotherapy, and immunotherapy.

There are currently 9 head and neck cancer clinical trials recruiting participants in Atlanta, GEORGIA. These studies are seeking a combined 2,515 participants. Research is being sponsored by Canadian Cancer Trials Group, Johnson & Johnson Enterprise Innovation Inc., AVEO Pharmaceuticals, Inc. and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Head and Neck Cancer Clinical Trials in Atlanta — FAQ

Are there head and neck cancer clinical trials in Atlanta?

Yes, there are 9 head and neck cancer clinical trials currently recruiting in Atlanta, GEORGIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Atlanta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you about next steps.

Are clinical trials in Atlanta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Atlanta studies also compensate for your time and travel.

What head and neck cancer treatments are being tested?

The 9 active trials in Atlanta are testing new therapies including novel drugs, biologics, and treatment approaches for head and neck cancer.

Data updated March 2, 2026 from ClinicalTrials.gov